Why is CAP accreditation important in genetic testing?
Genetic testing has become an essential tool in modern medicine, particularly with the increasing use of molecular analysis to detect genetic variations associated with hereditary diseases, certain types of cancer, and predisposition to some health conditions. As reliance on genetic test results in medical decision-making grows, it is no longer just about undergoing the test itself, but also about ensuring the quality of the laboratory and the accuracy of the procedures used to analyze samples and produce results.
This is where CAP – College of American Pathologists accreditation comes in, as it is one of the frameworks for accrediting medical laboratories that focuses on applying rigorous standards of quality, efficiency, and safety in testing procedures. The CAP program includes specializations directly related to molecular and genetic testing, including Inherited Genetics within the field of Molecular Pathology.
What is CAP accreditation?
CAP accreditation is a qualification awarded to a laboratory after it has met specific requirements and standards, compliance with which is assessed through a structured inspection process. The program relies on specialized checklists that are updated regularly and cover various aspects of laboratory operations, such as quality management, sample handling, verification of testing methods, quality control, equipment, and documentation of results and procedures.
It's not just about having modern equipment in the lab, because the quality of genetic testing depends on a complete series of steps starting with proper handling of the sample, then extracting and analyzing the genetic material, and finally interpreting the result and issuing the report.
Therefore, having a clear and consistently applied quality system is an essential part of the reliability of genetic testing.
Why is CAP important in genetic testing?
Genetic testing is characterized by its sensitivity and complexity; a physician may rely on the test results to assess a genetic condition, understand the cause of certain symptoms, or determine further diagnostic steps. Therefore, having clear quality assurance standards helps minimize the potential for errors and improve the consistency of results.
Current CAP listings indicate that the field of Molecular Pathology includes requirements specific to clinical molecular testing, including tests related to genetic diseases, tumor testing, and assays using techniques such as Sanger Sequencing and Next-Generation Sequencing (NGS). They also include requirements related to test validation, quality control, results interpretation, and reporting.
This makes laboratory accreditation according to CAP standards an important factor when assessing the quality of the environment in which genetic testing is conducted.
Enhancing test quality
One of the most important benefits of CAP standards is that they provide a clear framework for quality management within the laboratory. Genetic testing is not a single-stage process, but rather involves several stages, each of which can influence the final result.
This includes collecting and handling the sample appropriately, ensuring the suitability of the materials and equipment used, verifying the performance of the analytical methods, applying quality control procedures, documenting procedures and results, and reviewing the results before issuing the report.
This system helps to build a more consistent and revisable process, which is very important when dealing with genetic testing.
Verification of testing methods
An important point in genetic laboratories is to ensure that the method used to perform the test is appropriate for the required medical purpose and that its performance has been properly evaluated.
CAP requirements highlight the importance of Test Method Validation/Verification for non-exempt tests, and also include specialized requirements for verifying molecular tests.
This is particularly important in tests that rely on advanced technologies such as NGS, because obtaining genetic data is not the final step; rather, the quality of the method and the resulting data must be verified before relying on the result.
Improving quality control
Quality control is a fundamental element in any laboratory offering genetic testing.
Having clear procedures for monitoring test performance helps the laboratory identify and address potential problems before they affect the quality of results. CAP also includes requirements related to quality management, proficiency testing, policies and procedures, and the handling of samples and equipment.
This means that the quality of the test is not assessed only when a particular result appears, but rather through a continuous system of monitoring laboratory performance.
The importance of accreditation when using NGS technologies
Recent years have witnessed a significant expansion in the use of Next-Generation Sequencing (NGS) in the medical field, both in genetic diseases and certain oncology applications.
These techniques require meticulous procedures encompassing test design, performance verification, quality control, data analysis, results interpretation, and final reporting. CAP specifies requirements and reviews related to laboratories using NGS in genetic testing, focusing on aspects such as validation, quality control, interpretation, and result reporting.
Therefore, choosing a laboratory that applies recognized quality standards can be an important element when conducting genetic tests using modern technologies.
Increased confidence in the results of genetic tests
When a patient is looking for a place to have a genetic test done, it is natural for them to be concerned about the accuracy of the result and the reliability of the laboratory performing the analysis.
Having an accreditation like CAP indicates that a laboratory operates within a structured framework for quality assessment and adherence to standards. The CAP program relies on inspections by laboratory specialists, using detailed checklists to evaluate compliance with quality requirements.
Here, an important point must be emphasized: CAP accreditation does not mean that every genetic result will be correct in every case or that the test is suitable for every person, but it indicates the existence of a quality system and operational standards against which the laboratory is evaluated.
From sample to report: Quality at every step
Some may think that the accuracy of genetic tests depends solely on the analyzer, but the truth is that the process begins before the device is even turned on.
Sample quality, preservation methods, DNA or RNA extraction, genetic material quality, analytical methods, bioinformatics in sequencing-based tests, interpretation of genetic variants, and report writing are all steps that can influence the final result.
Therefore, having a comprehensive quality system within the laboratory is of great importance.
CAP explains that accreditation lists include elements such as sample handling, quality management, results preparation, reagents, equipment maintenance, verification of test methods, and other laboratory operating requirements.
What does this mean for the patient?
When considering genetic testing, it is important that the question is not just: What is the name of the test?
One can also consider a range of questions, such as
Where is the test conducted?
Does the laboratory apply recognized quality standards?
What type of technology is used?
Has the testing method been verified?
How are the samples handled?
How are the results interpreted?
Is the report issued by qualified professionals?
These questions help to form a more comprehensive picture of the quality of service provided.
Genetic testing at Enigma Genomics
At Enigma Genomics, attention to the quality of genetic testing is an important part of delivering genomic medicine services responsibly, because the goal of testing is not just to get a result, but to access genetic information that can be understood and used in the appropriate medical context.
Choosing the appropriate test and interpreting the result remains a step that requires specialized medical evaluation, because the presence of a genetic change in the report does not necessarily mean the presence of a disease, and the meaning of the result may vary according to medical and family history, symptoms, and the type of genetic change.
Therefore, Enigma Genomics is committed to providing services related to genetic medicine, emphasizing the importance of correctly understanding the results and not treating the genetic report in isolation from specialized medical evaluation.
Genetic testing has become an increasingly important part of modern medicine, and with this development, the quality of the laboratory performing these tests has become an indispensable element.
CAP accreditation is a key indicator of a well-organized laboratory quality management system, especially since CAP requirements encompass areas directly related to Molecular Pathology and Inherited Genetics, in addition to verifying testing methods, quality control, interpreting results, and preparing reports.
However, accreditation should be viewed as part of a quality system and not a substitute for medical evaluation or expert consultation. The appropriate genetic test is the one chosen based on the medical condition, and its results are interpreted within their proper context.
Therefore, when researching genetic testing, it is important to look beyond the test's name and price, and to ensure the quality of the laboratory, the techniques used, the quality system, and the method of interpreting the results.
Enigma Genomics seeks to raise awareness of the importance of genetic medicine and the role of genetic testing in accessing information that helps in understanding genetic conditions and making more informed medical decisions, with the importance of consulting specialists to interpret results and choose the appropriate tests for each case.